1.40Open1.40Pre Close0 Volume719 Open Interest10.00Strike Price0.00Turnover42.34%IV1.69%PremiumDec 20, 2024Expiry Date1.21Intrinsic Value100Multiplier21DDays to Expiry0.19Extrinsic Value100Contract SizeAmericanOptions Type0.8862Delta0.1703Gamma8.62Leverage Ratio-0.0063Theta0.0049Rho7.64Eff Leverage0.0051Vega
Indivior Stock Discussion
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
• Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the...
No comment yet